Survey of Clinical Translation of Cancer Nanomedicines—Lessons Learned from Successes and Failures-Reference-Cited by-同舟云学术

Survey of Clinical Translation of Cancer Nanomedicines—Lessons Learned from Successes and Failures

Published:2019-08-19 Issue:9 Volume:52 Page:2445-2461
ISSN:0001-4842
Container-title:Accounts of Chemical Research
language:en
Short-container-title:Acc. Chem. Res.

Author:

He Hongliang¹,Liu Lisha¹,Morin Emily E.¹,Liu Min²,Schwendeman Anna¹³^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, 428 Church Street, Ann Arbor, Michigan 48109, United States

2. Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 200032, PR China

3. Biointerfaces Institute, NCRC Building, 2800 Plymouth Road, Ann Arbor, Michigan 48109, United States

Publisher

American Chemical Society (ACS)

Subject

General Medicine,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.accounts.9b00228

Reference59 articles.

1. Cancer Facts & Figures of 2018. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf (accessed July 1, 2019).

2. Nanocarriers as an emerging platform for cancer therapy

3. Treating metastatic cancer with nanotechnology

4. Impact of Nanotechnology on Drug Delivery

5. Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

Cited by 371 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioconjugated clicked chitosan/alginate nanocarriers with trastuzumab: Unlocking curcumin's potential in targeting breast cancer;Carbohydrate Polymer Technologies and Applications;2024-12

2. A translational framework to DELIVER nanomedicines to the clinic;Nature Nanotechnology;2024-09-06

3. Clinical translation of nanomedicine with integrated digital medicine and machine learning interventions;Colloids and Surfaces B: Biointerfaces;2024-09

4. Tumor-targeting drug delivery regimens based on vascular disrupting agents;Precision Medicine and Engineering;2024-09

5. Next-generation aluminum adjuvants: Immunomodulatory layered double hydroxides NanoAlum reengineered from first-line drugs;Acta Pharmaceutica Sinica B;2024-09